{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:56:45Z","timestamp":1788418605197,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T00:00:00Z","timestamp":1262649600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s00467-009-1377-5","type":"journal-article","created":{"date-parts":[[2010,1,4]],"date-time":"2010-01-04T09:19:13Z","timestamp":1262596753000},"page":"539-544","source":"Crossref","is-referenced-by-count":83,"title":["Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine"],"prefix":"10.1007","volume":"25","author":[{"given":"Shuichiro","family":"Fujinaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daishi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Nishizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Ohtomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,5]]},"reference":[{"key":"1377_CR1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MOP.0b013e3282f4307a","volume":"20","author":"EM Hodson","year":"2008","unstructured":"Hodson EM, Alexander SI (2008) Evaluation and management of steroid-sensitive nephrotic syndrome. Curr Opin Pediatr 20:145\u2013150","journal-title":"Curr Opin Pediatr"},{"key":"1377_CR2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.ajkd.2007.02.270","volume":"49","author":"HA Kyrieleis","year":"2007","unstructured":"Kyrieleis HA, Levtchenko EN, Wetzels JF (2007) Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome. Am J Kidney Dis 49:592\u2013597","journal-title":"Am J Kidney Dis"},{"key":"1377_CR3","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1442-200X.2007.02487.x","volume":"49","author":"M Okada","year":"2007","unstructured":"Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T (2007) Mycophenolate mofetil therapy for children with intractable nephrotic syndrome. Pediatr Int 49:933\u2013937","journal-title":"Pediatr Int"},{"key":"1377_CR4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s00467-004-1434-z","volume":"19","author":"K Benz","year":"2004","unstructured":"Benz K, D\u00f6tsch J, Rascher W, Stachel D (2004) Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 19:794\u2013797","journal-title":"Pediatr Nephrol"},{"key":"1377_CR5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00467-006-0427-5","volume":"22","author":"GC Smith","year":"2007","unstructured":"Smith GC (2007) Is there a role for rituximab in the treatment of idiopathic childhood nephrotic syndrome? Pediatr Nephrol 22:893\u2013898","journal-title":"Pediatr Nephrol"},{"key":"1377_CR6","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1007\/s00467-006-0228-x","volume":"21","author":"RD Gilbert","year":"2006","unstructured":"Gilbert RD, Hulse E, Rigden S (2006) Rituximab therapy for steroid-dependent minimal change nephrotic syndrome. Pediatr Nephrol 21:1698\u20131700","journal-title":"Pediatr Nephrol"},{"key":"1377_CR7","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","volume":"23","author":"V Guigonis","year":"2008","unstructured":"Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F (2008) Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23:1269\u20131279","journal-title":"Pediatr Nephrol"},{"key":"1377_CR8","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00467-009-1191-0","volume":"24","author":"K Kamei","year":"2009","unstructured":"Kamei K, Ito S, Nozu K, Fujinaga S, Nakayama M, Sako M, Saito M, Yoneko M, Iijima K (2009) Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol 24:1321\u20131328","journal-title":"Pediatr Nephrol"},{"key":"1377_CR9","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/adc.2005.080960","volume":"91","author":"S Fujinaga","year":"2006","unstructured":"Fujinaga S, Kaneko K, Muto T, Ohtomo Y, Murakami H, Yamashiro Y (2006) Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome. Arch Dis Child 91:666\u2013670","journal-title":"Arch Dis Child"},{"key":"1377_CR10","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00467-005-1932-7","volume":"20","author":"S Fujinaga","year":"2005","unstructured":"Fujinaga S, Kaneko K, Takada M, Ohtomo Y, Akashi S, Yamashiro Y (2005) Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome. Pediatr Nephrol 20:1359\u20131360","journal-title":"Pediatr Nephrol"},{"key":"1377_CR11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00467-006-0294-0","volume":"22","author":"S Fujinaga","year":"2007","unstructured":"Fujinaga S, Ohtomo Y, Umino D, Takemoto M, Shimizu T, Yamashiro Y, Kaneko K (2007) A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome. Pediatr Nephrol 22:71\u201376","journal-title":"Pediatr Nephrol"},{"key":"1377_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1620\/tjem.214.27","volume":"214","author":"H Komiya","year":"2008","unstructured":"Komiya H, Masubuchi Y, Mori Y, Tajima N (2008) The validity of body mass index criteria in obese school-age children. Tohoku J Exp Med 214:27\u201337","journal-title":"Tohoku J Exp Med"},{"key":"1377_CR13","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub RJ (1974) Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 2:556\u2013560","journal-title":"Lancet"},{"key":"1377_CR14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ndt\/18.2.245","volume":"18","author":"P Grimbert","year":"2003","unstructured":"Grimbert P, Audard V, Remy P, Lang P, Sahali D (2003) Recent approaches to the pathogenesis of minimal-change nephrotic syndrome. Nephrol Dial Transplant 18:245\u2013248","journal-title":"Nephrol Dial Transplant"},{"key":"1377_CR15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5414\/CNP60242","volume":"60","author":"MJ Kemper","year":"2003","unstructured":"Kemper MJ, Meyer-Jark T, Lilova M, M\u00fcller-Wiefel DE (2003) Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clin Nephrol 60:242\u2013247","journal-title":"Clin Nephrol"},{"key":"1377_CR16","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1007\/s00467-009-1226-6","volume":"24","author":"D Haffner","year":"2009","unstructured":"Haffner D, Fischer DC (2009) Nephrotic syndrome and rituximab: facts and perspectives. Pediatr Nephrol 24:1433\u20131438","journal-title":"Pediatr Nephrol"},{"key":"1377_CR17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1053\/j.ajkd.2006.10.015","volume":"49","author":"H Fran\u00e7ois","year":"2007","unstructured":"Fran\u00e7ois H, Daugas E, Bensman A, Ronco P (2007) Unexpected efficacy of rituximab in multirelapsing minimal change nephrotic syndrome in the adult: first case report and pathophysiological considerations. Am J Kidney Dis 49:158\u2013161","journal-title":"Am J Kidney Dis"},{"key":"1377_CR18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00467-007-0596-x","volume":"23","author":"J D\u00f6tsch","year":"2008","unstructured":"D\u00f6tsch J, M\u00fcller-Wiefel DE, Kemper MJ (2008) Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible? Pediatr Nephrol 23:3\u20137","journal-title":"Pediatr Nephrol"},{"key":"1377_CR19","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00467-008-1030-8","volume":"24","author":"AP Sharma","year":"2009","unstructured":"Sharma AP, Filler G (2009) Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab. Pediatr Nephrol 24:423\u2013424","journal-title":"Pediatr Nephrol"},{"key":"1377_CR20","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1056\/NEJMc063706","volume":"356","author":"A Bagga","year":"2007","unstructured":"Bagga A, Sinha A, Moudgil A (2007) Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med 356:2751\u20132752","journal-title":"N Engl J Med"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-009-1377-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-009-1377-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-009-1377-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:45:14Z","timestamp":1559090714000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-009-1377-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["1377"],"URL":"https:\/\/doi.org\/10.1007\/s00467-009-1377-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,5]]}}}